Literature DB >> 19757169

The influence of ADAR1's regulation on lymphocyte cell function during rejection.

Lei Cai1, Yan Li, Feng Liu, Wei Zhang, Binliang Huo, Wei Zheng, Rui Ding, Jiyuan Guo, Qingchuan Zhao, Kefeng Dou.   

Abstract

The RNA editing adenosine deaminase gene (ADAR1) expression is wide-spread in lymphocytes. We explore the mechanism of ADAR1 regulation on the function of T primary lymphocytes when rejection occurs by knock-down the expression of ADAR1 in mouse T primary lymphocytes in mixed lymphocyte cultures. The changes of cell proliferation, the expression of ADAR1 and the cell cycle related genes cyclin D1 and A1, cell cycle and apoptosis analysis and mouse gene expression profiles was evaluated. We found that treatment with ADAR1-specific siRNA inhibited allogenic antigen stimulated T cell proliferation, arrested T cell cycle at G(0)/G(1) phases and promoted T cell apoptosis, which was associated with down-regulation of some related key genes transcription. These findings suggest that ADAR1 is essential for the maintenance of function of T lymphocytes during acute rejection. The mechanism underlying ADAR1's action might include editing of a currently unknown substrate and interacting with other proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757169     DOI: 10.1007/s11033-009-9804-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

Review 1.  A novel cytidine deaminase affects antibody diversity.

Authors:  A Longacre; U Storb
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

2.  Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection.

Authors:  Yongzhan Nie; Graeme L Hammond; Jing-Hua Yang
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Mutation of DNA primase causes extensive apoptosis of retinal neurons through the activation of DNA damage checkpoint and tumor suppressor p53.

Authors:  Masahiro Yamaguchi; Noriko Fujimori-Tonou; Yukihiro Yoshimura; Tsutomu Kishi; Hitoshi Okamoto; Ichiro Masai
Journal:  Development       Date:  2008-02-20       Impact factor: 6.868

4.  Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.

Authors:  Pål Falck; Anders Asberg; Heidi Guldseth; Sara Bremer; Fatemeh Akhlaghi; Jan L E Reubsaet; Per Pfeffer; Anders Hartmann; Karsten Midtvedt
Journal:  Transplantation       Date:  2008-01-27       Impact factor: 4.939

5.  Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)-->signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3.

Authors:  Rehan Ahmad; Deepak Raina; Colin Meyer; Donald Kufe
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

6.  Cell cycle-dependent regulation of SFK, JAK1 and STAT3 signalling by the protein tyrosine phosphatase TCPTP.

Authors:  Ben J Shields; Naomi W Court; Christine Hauser; Patricia E Bukczynska; Tony Tiganis
Journal:  Cell Cycle       Date:  2008-11-08       Impact factor: 4.534

7.  Essential role of sphingosine-1-phosphate receptor 1-bearing CD8+CD44+CCR7+ T cells in acute skin allograft rejection.

Authors:  H Yuling; X Ruijing; J Xiang; X Luokun; Y Wenjun; C Feng; H Baojun; Y Hui; Y Guang; Y Chunlei; Z Jixin; C Lang; Q Li; A Chang; B Zhuan; J Youxin; G Feili; T Jinquan
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

8.  Bacterial ligand of TLR2 signals Stat activation via induction of IRF1/2 and interferon-alpha production.

Authors:  Mari Liljeroos; Reetta Vuolteenaho; Samuli Rounioja; Birgitta Henriques-Normark; Mikko Hallman; Marja Ojaniemi
Journal:  Cell Signal       Date:  2008-07-02       Impact factor: 4.315

9.  Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene.

Authors:  Qingde Wang; Mana Miyakoda; Weidong Yang; Jaspal Khillan; David L Stachura; Mitchell J Weiss; Kazuko Nishikura
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

10.  Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.

Authors:  Eun Goo Jeong; Min Sung Kim; Hyo Kyung Nam; Chang Ki Min; Seok Lee; Yeun Jun Chung; Nam Jin Yoo; Sug Hyung Lee
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

View more
  3 in total

Review 1.  Glutamate receptors and signal transduction in learning and memory.

Authors:  Sheng Peng; Yan Zhang; Jiannan Zhang; Hua Wang; Bingxu Ren
Journal:  Mol Biol Rep       Date:  2010-04-03       Impact factor: 2.316

2.  Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.

Authors:  Jennifer L Hood; Michael V Morabito; Charles R Martinez; James A Gilbert; Elizabeth A Ferrick; Gregory D Ayers; James D Chappell; Terence S Dermody; Ronald B Emeson
Journal:  Mol Cell Neurosci       Date:  2014-06-04       Impact factor: 4.314

3.  A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme.

Authors:  Gilli Galore-Haskel; Yael Nemlich; Eyal Greenberg; Shira Ashkenazi; Motti Hakim; Orit Itzhaki; Noa Shoshani; Ronnie Shapira-Fromer; Eytan Ben-Ami; Efrat Ofek; Liat Anafi; Michal J Besser; Jacob Schachter; Gal Markel
Journal:  Oncotarget       Date:  2015-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.